These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 28296678)

  • 1. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
    Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y
    Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix.
    Kojima A; Mikami Y; Sudo T; Yamaguchi S; Kusanagi Y; Ito M; Nishimura R
    Am J Surg Pathol; 2007 May; 31(5):664-72. PubMed ID: 17460448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
    Ansari-Lari MA; Staebler A; Zaino RJ; Shah KV; Ronnett BM
    Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.
    Schwartz LE; Khani F; Bishop JA; Vang R; Epstein JI
    Am J Surg Pathol; 2016 Jan; 40(1):27-35. PubMed ID: 26426382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.
    Asaka S; Nakajima T; Kugo K; Kashiwagi R; Yazaki N; Miyamoto T; Uehara T; Ota H
    Virchows Arch; 2020 Apr; 476(4):499-510. PubMed ID: 31932920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
    Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
    Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in invasive adenocarcinoma of the cervix.
    Stolnicu S; Hoang L; Soslow RA
    Virchows Arch; 2019 Nov; 475(5):537-549. PubMed ID: 31209635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ER-positive endocervical adenocarcinoma mimicking endometrioid adenocarcinoma in morphology and immunohistochemical profile: A case report of application of HPV RNAscope detection.
    Chen R; Qin P; Luo Q; Yang W; Tan X; Cai T; Jiang Q; Chen H
    Medicine (Baltimore); 2021 Apr; 100(13):e24927. PubMed ID: 33787580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional Study.
    Bulutay P; Haberal N; Özen Ö; Erdem Ö; Zeren EH; Kulac İ; Taskiran Ç; Vatansever D; Ayhan A; Kapucuoğlu N
    Int J Gynecol Pathol; 2022 Sep; 41(5):447-458. PubMed ID: 34856570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
    Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
    Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
    Zhang CN; Liu XY; Li Q; Song YZ; Liu B; Yin J; Yang JH; Zhong L; Sun L; Zhang X; Chen W
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):402-409. PubMed ID: 37188625
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
    Jones MW; Onisko A; Dabbs DJ; Elishaev E; Chiosea S; Bhargava R
    Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
    Kong CS; Beck AH; Longacre TA
    Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.